Skip to content

Cumberland Pharmaceuticals CPIX Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

PTH
Pelthos Therapeutics Inc.PTHS
$3.15M
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$785K-39.8%
Opko Health logo
Opko HealthOPK
$45.8M-4.2%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$12.65M+65.0%
Baxter International logo
Baxter InternationalBAX
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+138%
Enterprise value$90.91M+207%
P/S2.3×+1.3×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's operating lease ROU assets?
Cumberland Pharmaceuticals (CPIX) reported operating lease ROU assets of $7.62M in Q1 2026.
How has Cumberland Pharmaceuticals's operating lease ROU assets changed year-over-year?
Cumberland Pharmaceuticals's operating lease ROU assets increased by 6.1% year-over-year, from $7.18M to $7.62M.
What is the long-term trend for Cumberland Pharmaceuticals's operating lease ROU assets?
Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's operating lease ROU assets has grown at a 32.7% compound annual growth rate (CAGR), from $2.03M to $8.34M.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.